Skip to main content
Fig. 5 | Critical Care

Fig. 5

From: Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

Fig. 5

Probability of target attainment (PTA) in ELF of different dosages regimens. PTA in ELF of different dosages of meropenem: 2 g loading dose (LD) followed by 1 g/8 h, 2 g LD followed by 2 g/8 h, and 3 g LD followed by 3 g/8 h; administered as a continuous infusion during the third day of treatment (from 48 to 72 h after the start of the treatment)

Back to article page

Critical Care

ISSN: 1364-8535